MAJOR PIVOT — HHS OCR Extends Section 504 / WCAG 2.1AA Deadline by One Year to May 11, 2027

On May 7, 2026 — four days before the original deadline — HHS Office for Civil Rights issued an Interim Final Rule extending the Section 504 digital accessibility compliance date by one year. FQHCs with 15+ employees now have until May 11, 2027 to make websites, mobile apps, patient portals, online scheduling, telehealth platforms, intake forms, and self-service kiosks WCAG 2.1 Level AA compliant. Recipients with fewer than 15 employees have until May 10, 2028. OCR cited concerns that FQHCs, hospitals, and primary care centers could not meet the original deadline. Comment period runs through July 6, 2026. CRITICAL: this is an extension, not a rescission — Section 504 has been enforceable since July 8, 2024, the private right of action remains active, and ADA-related healthcare litigation grew 11% YoY in 2025. FQHCs should use the 12-month runway to: (1) complete an accessibility audit, (2) publish accessibility statement + complaint intake procedure, (3) train front-desk staff, (4) document good-faith remediation milestones. For FQHCs that were sprinting to remediate, this is genuine relief; for those who deferred, the underlying obligation has not changed.

NACHC Warns Senate Finance: Reconciliation Bill Would Cut $7B from Community Health Centers Over 10 Years — 'The Most Significant Threat in 60 Years'

NACHC submitted formal testimony to the Senate Finance Committee warning that H.R. 1's combined Medicaid provisions — per-capita caps, work requirements, FMAP reductions, and Section 330 grant cuts — would eliminate $7B in community health center funding over 10 years, close an estimated 1 in 5 health centers, and displace 7.6M patients. NACHC CEO Gerard Clancy called it 'the most significant threat to the health center movement in 60 years.' The testimony is being circulated directly to Senate moderates (Collins, Murkowski, Capito) as budget reconciliation negotiations intensify.

AbbVie Sues HRSA in D.C. District Court Over 340B Patient Definition — Post-Chevron Doctrinal Weapon

AbbVie filed a 72-page complaint April 8 in U.S. District Court for the District of Columbia against HRSA, HHS, Secretary Kennedy, and HRSA Administrator Engels — targeting the 1996 'patient definition' guidance that allows 340B drugs to be dispensed to non-FQHC contract patients. Post-Chevron doctrinal weapon: AbbVie argues HRSA's interpretive guidance lacks force of law. If successful, would dramatically narrow which patients qualify for 340B savings and gut FQHC contract pharmacy revenue. Joins the pending Maine District Court case (AHA + 4 safety-net hospitals, already vacated rebate model in Feb 2026). Combined regulatory + litigation pressure on HRSA's 340B authority is the most concentrated industry challenge in program history.